Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J R Desborough

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Gastroenterology|June 1, 2014
Is treatment of moderate thrombocytopenia indicated for patients with HCV infection and cirrhosis?Michael J R Desborough, Vipul Jairath
Lancet (London, England)|July 8, 2014
New oral anticoagulants in patients with atrial fibrillationMichael J R Desborough, Vipul Jairath
Hepatology (Baltimore, Md.)|November 9, 2015
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathyMichael J R Desborough, Vipul Jairath
British Journal of Haematology|January 21, 2017
The aspirin story - from willow to wonder drugMichael J R Desborough, David M Keeling
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 23, 2020
Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and managementWill Thomas, Kate Downes, Michael J R Desborough
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2017
Response to prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairmentMichael J R Desborough, Simon J Stanworth, Vipul Jairath
Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Can drug-induced platelet dysfunction be reversed?Suzanne Maynard, Alexander P Bye, Michael J R Desborough
British Journal of Haematology|February 23, 2018
Factor XIa-triggered thrombin generation in severe haemophilia AMichael J R Desborough, Hassan Naeem, Peter Baker, et al.
British Journal of Haematology|May 14, 2023
Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpuraAsha Aggarwal, Danielle White, Sue Pavord, et al.
Hepatology (Baltimore, Md.)|November 5, 2016
Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleedingMichael J R Desborough, Brennan C Kahan, Simon J Stanworth, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Gastroenterology|June 1, 2014
Is treatment of moderate thrombocytopenia indicated for patients with HCV infection and cirrhosis?Michael J R Desborough, Vipul Jairath
Lancet (London, England)|July 8, 2014
New oral anticoagulants in patients with atrial fibrillationMichael J R Desborough, Vipul Jairath
Hepatology (Baltimore, Md.)|November 9, 2015
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathyMichael J R Desborough, Vipul Jairath
British Journal of Haematology|January 21, 2017
The aspirin story - from willow to wonder drugMichael J R Desborough, David M Keeling
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 23, 2020
Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and managementWill Thomas, Kate Downes, Michael J R Desborough
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2017
Response to prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairmentMichael J R Desborough, Simon J Stanworth, Vipul Jairath
Research and Practice in Thrombosis and Haemostasis|January 16, 2026
Can drug-induced platelet dysfunction be reversed?Suzanne Maynard, Alexander P Bye, Michael J R Desborough
British Journal of Haematology|February 23, 2018
Factor XIa-triggered thrombin generation in severe haemophilia AMichael J R Desborough, Hassan Naeem, Peter Baker, et al.
British Journal of Haematology|May 14, 2023
Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpuraAsha Aggarwal, Danielle White, Sue Pavord, et al.
Hepatology (Baltimore, Md.)|November 5, 2016
Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleedingMichael J R Desborough, Brennan C Kahan, Simon J Stanworth, et al.
Pageof 4